Search results
Results from the WOW.Com Content Network
The thrombosis events associated with the COVID‑19 vaccine may occur 4–28 days after its administration and mainly affects women under 55. [ 6 ] [ 2 ] [ 20 ] Several relatively unusual types of thrombosis were specifically reported to be occurring in those with the reaction: cerebral venous sinus thrombosis and thrombosis of the splanchnic ...
People who have had COVID-19 are at a greater risk for diabetes, even with Omicron, research finds. Experts explain the correlation between diabetes and COVID.
New research published in the journal BMC Medicine this month sheds light on how patients who have contracted COVID-19 are at greater risk of developing diabetes — both type 1 and type 2.
People may be at increased risk for developing diabetes for up to a year after a diagnosis of COVID-19, according to two studies. One study used data from the U.S. Department of Veterans Affairs ...
Pancreatic cancer rarely occurs before the age of 40, and more than half of cases of pancreatic adenocarcinoma occur in those over 70. [2] Risk factors for pancreatic cancer include tobacco smoking, obesity, diabetes, and certain rare genetic conditions. [2] About 25% of cases are linked to smoking, [3] and 5–10% are linked to inherited genes ...
Because cases of thrombosis with thrombocytopenia syndrome and Guillain-Barré syndrome have been reported after receipt of the Janssen COVID‑19 vaccine, the US Centers for Disease Control and Prevention (CDC) recommends "preferential use of mRNA COVID‑19 vaccines over the Janssen COVID‑19 vaccine, including both primary and booster doses ...
An old and commonly prescribed diabetes medication may help significantly lower the risk of developing long COVID, recently released drug trial data show.. The trial, conducted by a team of ...
The vaccine consists of a version of the receptor binding domain (RBD) of the SARS‑CoV‑2 spike protein, together with the adjuvants aluminium hydroxide gel and CpG 1018. [2] As the RBD protein is poorly immunogenic alone, adjuvantation is essential for a RBD-based vaccine immunogenicity. [ 9 ]